Skip to main content

An end to wine headaches at last

Thank food biotechnologist Hennie van Vuuren at the University of British Columbia for finding the solution to one of the most vexing problems for would-be wine lovers: the headache that so often accompanies wine drinking for up to 30% of the population. These unfortunate folks are sensitive to compounds known as biogenic amines such as histamine, which can also impart off-putting flavors to wines. (It isn't the sulfites.) I have long thought that there was a huge opportunity for someone to crack this particularly hard nut and figure out how to make low-amine wines.


van Vuuren apparently had the same idea, and over the past several years he has been developing a strain of yeast for wine fermentation that produces low levels of amines. The yeast, known as Malolactic ML101, has already been approved by Health Canada and the US Food and Drug Administration. According to the developers of the new yeast, Lesaffre Yeast Corporation, there is a good chance you have had wine produced with ML101 without knowing it, since it doesn’t require any special labeling. If you ask me though, they are missing an opportunity to spread the good news to the millions who have been avoiding wine for fear of triggering a migraine.

There is of course a catch in that the FDA and other regulatory agencies in the U.S. take a dim view of winemakers claiming any health benefits about wine, despite the massive amount of supportive data on the subject across a wide range of conditions. That leaves it up to independent wine and health experts (such as yours truly) to spread the word. So winemakers, if you are using ML101 let us know, and consumers, let’s talk it up especially to our friends who have been unable to enjoy wine. (The only winery to confirm that they are using ML101 is Sandhill Winery in British Columbia, though several American wineries do as well.)

Comments

Popular posts from this blog

Wear red and DRINK red for women’s heart health

This Friday Feb 2nd is the annual “wear red” day in Canada and the U.S. to raise awareness for women’s heart health. Why only a day for the number one threat to women’s health? Women are 5 times more likely to succumb to heart disease than breast cancer, which gets a whole month (October.) Another contradiction is that the advice women hear about prevention of breast cancer is the opposite of what you can do to lower the risk of heart disease: a daily glass of wine. Even one drink a day raises your risk of breast cancer, we are told, ignoring the overriding benefits of wine on heart health. Drink red wine to live longer Here’s why I think women should also “drink red.” For starters, wine helps de-stress and celebrates life. Stress is a factor in heart disease, and if that were the only way wine helped it would be worth considering. But the medical evidence is also strong: a daily glass of red wine helps raise the HDL “good cholesterol” levels, which lowers the risk of cardiovascular p…

Which types of wine are the healthiest?

I am often asked after lecturing on the healthful properties of wine which type is best to drink. Since much of the discussion has to do with the polyphenol antioxidants from the skins and seeds of the grape, red wine is the first criterion since it is fermented with the whole grape rather than the pressed juice. This allows for extraction and concentration of these compounds, familiar ones being resveratrol and tannins. But beyond that, which varietals have the highest concentrations?


According to the Roman philosopher Pliny the Elder, “The best kind of wine is that which is pleasant to him that drinks it” but modern science expects more specifics. (The point of course is that if you have a wine that you enjoy you are more likely to drink regularly and therefore reap the benefits.) But there are several difficulties in singling out certain wines for their healthful properties. Which compounds to measure? Are we talking about heart health or the whole gamut? Is it the varietal of the …

The J-curve is dead. Long live the J-curve!

There is a resurgence of debate about the validity of the J-curve, especially as it relates to alcohol and cancer. A 2014 report determined that “alcohol use was positively associated with overall mortality, alcohol-related cancers, and violent death and injuries, but marginally to CVD/CHD” (cardiovascular disease). In other words, there was little benefit if any in terms of heart disease but a big upside risk for cancer and accidental or violent demise. Gone was the French Paradox! The J curve is dead! Or not. Though that statement may be technically true, I looked at look at the data myself and found something different: a strong confirmation of the J-curve for overall mortality, overall cancer deaths, cardiovascular disease, and all “other causes.” This held for both men and women:
    Used under creative commons license from Ferrari P, Licaj I,Muller DC, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nu…